Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rapid Micro Biosystems (RPID) Net Income (2020 - 2025)

Rapid Micro Biosystems' Net Income history spans 6 years, with the latest figure at -$11.5 million for Q3 2025.

  • For Q3 2025, Net Income fell 1.61% year-over-year to -$11.5 million; the TTM value through Sep 2025 reached -$44.3 million, up 8.48%, while the annual FY2024 figure was -$46.9 million, 10.63% up from the prior year.
  • Net Income for Q3 2025 was -$11.5 million at Rapid Micro Biosystems, up from -$11.9 million in the prior quarter.
  • Across five years, Net Income topped out at -$9.7 million in Q4 2024 and bottomed at -$25.0 million in Q3 2021.
  • The 5-year median for Net Income is -$13.3 million (2024), against an average of -$14.1 million.
  • The largest annual shift saw Net Income plummeted 195.18% in 2021 before it surged 34.61% in 2022.
  • A 5-year view of Net Income shows it stood at -$14.6 million in 2021, then decreased by 12.61% to -$16.4 million in 2022, then skyrocketed by 32.07% to -$11.2 million in 2023, then increased by 13.48% to -$9.7 million in 2024, then decreased by 19.03% to -$11.5 million in 2025.
  • Per Business Quant, the three most recent readings for RPID's Net Income are -$11.5 million (Q3 2025), -$11.9 million (Q2 2025), and -$11.3 million (Q1 2025).